Eliadna de Lemos Vasconcelos Silva

Eliadna de Lemos Vasconcelos Silva

Auto-generated profile, based on publicly available information

Eliadna de Lemos Vasconcelos Silva

Quality Control Core of Medicines and Correlates - NCQMC, Department of Pharmaceutical Sciences, Federal University of Pernambuco, Recife, PE, Brazil

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2021 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
YPYuri Basilio Gomes Patriota
Yuri Basilio Gomes Patriota
IAIgor Eduardo Silva Arruda
Igor Eduardo Silva Arruda
AOAntonia Carla Oliveira
Antonia Carla Oliveira
TOThaisa Cardoso de Oliveira
Thaisa Cardoso de Oliveira
ESEliadna de Lemos Vasconcelos Silva
Eliadna de Lemos Vasconcelos Silva
JSJosé Lamartine Soares Sobrinho
José Lamartine Soares Sobrinho

5 May 2023 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
ESEliadna de Lemos Vasconcelos Silva
Eliadna de Lemos Vasconcelos Silva
AOAntonia Carla Oliveira
Antonia Carla Oliveira
LMLívia Maria Coelho de Carvalho Moreira
Lívia Maria Coelho de Carvalho Moreira
Edson Silva FilhoEdson Silva Filho
Edson Silva Filho
AWAlmir Gonçalves Wanderley
Almir Gonçalves Wanderley
JSJosé Lamartine Soares Sobrinho
José Lamartine Soares Sobrinho

1 January 2019 in Matéria (Rio de Janeiro)
Verified
Journal Article
Open access
PDF file
ESEliadna de Lemos Vasconcelos Silva
Eliadna de Lemos Vasconcelos Silva
AOAntonia Carla Oliveira
Antonia Carla Oliveira
Edson Silva FilhoEdson Silva Filho
Edson Silva Filho
ARAntonio Ribeiro
Antonio Ribeiro
Francisco VeigaFrancisco Veiga
Francisco Veiga
JSJosé Lamartine Soares Sobrinho
José Lamartine Soares Sobrinho
The subcutaneous administration of insulin has been the treatment of millions of diabetics in the world. However, for such via insulin is invasive and not mimics the physiological action causing side effects. The oral route would be the most physiological and comfortable option, but the oral bioavailability of insulin is low by proteolytic activity and reduced permeability of the gastrointestinal tract. The aim of the study was to develop a nanostructured system integrating biomaterials for oral insulin delivery. Cashew gum (CG) is a polysaccharide extracted from the exudate of the plant Anacardium occidentale. It is a biopolymer composed of simple sugars and glucuronic acid and it can be used in nanostructured systems for the incorporation of molecules. The exudate was isolated, dissolved in water, filtered, precipitated in ethanol and purified. The CG was characterized by infrared spectroscopy and molecular weight by size exclusion chromatography. Nanoparticles were prepared through ionotropic gelation integrating cashew gum, dextran sulfate and poloxamer containing insulin stabilized with chitosan, poly(ethyleneglycol) and coated with albumin. The particles were analyzed for particle size, zeta potential and insulin entrapment efficiency. The FTIR spectrum for CG showed a band at 3395 cm-1 due to the stretching vibration of O-H, a band at 2926 cm-1 of C-H vibrations; absorption at 1639 cm-1 of O-H type from bound water molecules and bands at 1143, 1073 and 1024 cm-1 due vibrations of the C-O-C from glycosidic bonds and O-H of alcohols. The peak molar mass of GC was 2.35 × 104 g/mol. The particles had a size of 156 nm and after coating, size of 5387 nm with 92% insulin entrapment efficiency and zeta potential of -51 mV indicating electrostatic stabilization. The results suggest an innovative cashew gum base system for oral insulin administration.